Work

An Analysis of Isoclonal Antibody Formats Suggests a Role for Measuring PD-L1 with Low Molecular Weight PET Radiotracers

Year: 2020

Type: article

Source: Molecular Imaging and Biology

DOI: 10.1007/s11307-020-01527-3

Authors: Junnian Wei, Yung-hua Wang, Chia Yin Lee, Charles Truillet, David Y. Oh, Yichen Xu, Davide Ruggero, Robert R. Flavell, Henry F. VanBrocklin, Youngho Seo, Charles S. Craik, Lawrence Fong, Cheng-I Wang, Michael J. Evans

Institutions: University of California, San Francisco, Agency for Science, Technology and Research, Singapore Immunology Network, Centre National de la Recherche Scientifique, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Université Paris-Saclay, CEA Paris-Saclay - Etablissement de Saclay, UCSF Helen Diller Family Comprehensive Cancer Center

Language: English

Topic: Radiopharmaceutical Chemistry and Applications

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: American Cancer Society, Prostate Cancer Foundation, National Institutes of Health, University of California, San Francisco, Biomedical Research Council, National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Center for Research Resources

Awards: Determinants of prostate cancer sensitivity to PD-1 blockade, G2139488668, G2342450115, G2927890194, Antibody Research Technology Center, G5036689762, Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies, MicroPET/CT for Small Animal Imaging, Molecular and immune drivers of immunotherapy responsiveness in prostate cancer, Mechanisms of Exosome Driven Immunoregulation of Cancer Progression, Cancer Center Support Grant, Mechanisms of regulated translation control in cancer and its therapeutic implications

OpenAlex ID: W3063949998

FWCI: 1.338

Cites: 19

Cited by: 14

Related to: 10